[First clinical experiences with parenteral administration of trimethiprim-sulfamethoxazole (Bactrim) in patients with artificial respiration in an intensive care unit].
D000328:Adult; D000403:Airway Resistance; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007362:Intensive Care Units; D010101:Oxygen Consumption; D011743:Pyrimidines / Q000627:therapeutic use*; D012121:Respiration, Artificial; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000503:physiopathology; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014692:Ventilation-Perfusion Ratio
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Erste klinische Erfahrungen mit der Erfahrungen mit der parenteralen Anwendung von Trimethoprim-Sulfamethoxazol (Bactrim) bei Beatmungspatienten einer Intensivstation.